Introduction of COPD
Defіnіtіon
Defіnіtіon of COPD The Global Іnіtіatіve for Obѕtrustіve Lung Dіѕeaѕe (GOLD) Guіdelіneѕ defіne COPD, chronic progreѕѕіve dіѕeaѕe, even after admіnіѕtratіon of Broncodіlatorѕ but not full reverѕіble aіrway obѕtructіon іѕ charasterіzed. The aіrway obѕtructіon іѕ cauѕed but mіxture of obѕtrustіve causes bronshіtіѕ and bronchial іnјuruy and іѕ an abnormal inflammatory with the lungs associated with harmful particles. Symptoms of COPD are chronic and progressive dyspnea, cough and sputum production. The diagnosis of COPD and backup is done in addition to the clinical diagnosis of the Spirometry. It should be assumed that COPD when the forced post bronchodilator force expiratory volume (FEV1) less than 80% of the
…show more content…
The diagnosis of COPD
The diagnosis of COPD is based, essentially, on a story of cigarette smoking or chronic inhalation of dusts, gases, or toxic and are confirmed by specific pulmonary function tests. Consider the possibility of COPD in smokers and ex-smokers over the age of 40 years
Spirometry
All international guidelines published in the last 5year [11,12]. Agree in Spirometry, with execution the maneuver of forced vital capacity (FVC), as an indispensable means for the diagnosis of COPD. The diagnosis is possible when the ratio of volume in the Expired first second (FEV1 according to the English acronym) and FVC (FEV1 / FVC), measured after administration of a bronchodilator (usually Salbutamol 400 mcg inhalation from dispensers pre-dosed), it is less than 0.70. In some works and some guidelines were discussed on the opportunities to use a single value of the FEV1 / FVC ratio to identify those who are suffering from COPD [13]. However, even if it agrees on the potential underestimation or overestimation of the disease, respectively in young and elderly, linked to the use of this method, the current unavailability reliable estimates of the distribution of the ratio valuesFEV1 / FVC in the various age groups, it blocks a diagnosis based on values below the 5th percentile of the Distribution FEV1 / FVC in the reference population, so far the 5th percentile was chosen by convention as the limitless of normal
R.W. appears with progressive difficulty getting his breath while doing simple tasks, and also having difficulty doing any manual work, complains of a cough, fatigue, and weight loss, and has been treated for three respiratory infections a year for the past 3 years. On physical examination, CNP notice clubbing of his fingers, use accessory muscles for respiration, wheezing in the lungs, and hyperresonance on percussion of the lungs, and also pulmonary function studies show an FEV1 of 58%. These all symptoms and history represented here most strongly indicate the probability of chronic obstructive pulmonary disease (COPD). COPD is a respiratory disease categorized by chronic airway inflammation, a decrease in lung function over time, and gradual damage in quality of life (Booker, 2014).
The purpose of this paper is to discuss an exacerbation of Chronic Obstructive Pulmonary Disease (COPD) and its effect on my patient, Mr. HS, a 78 year old male. In this paper we will look at the various facets in the disease process including its incidence, pathophysiology, presenting complaints, analysis of his clinical presentation, and discuss treatment. We will analyze the effect the disease process has on Mr. HS and will examine his clinical manifestations and laboratory work, as well as provide an outcome analysis. Understanding these various facets will enable one to understand
The information collected in the history was highly suggestive of COPD. One of the best predictors of airflow obstruction was the patient’s smoking history (Qaseem, et al., 2011, pp. 181). According to Qaseem, et al. (2011), the presence of the patient’s smoking history and wheezing on physical examination is indicative of airflow obstruction (pp. 181). Additionally, the patient’s presenting complaint was dyspnea on exertion, which is one of the most commonly presenting complaints in patients with COPD (Boardman, 2013, pp. 446). The chronic nature of the patient’s cough and slow progression of symptoms are consistent with a diagnosis of COPD rather than asthma. Finally, the diminished breath sounds on auscultation is indicative of airflow obstruction and considered to be a reliable finding in the diagnosis of COPD (Boardman, 2013, pp. 447). In addition to the new diagnosis of COPD, the patient also had current diagnoses of hypertension, hyperlipidemia, and osteoarthritis.
COPD is one of the greatest causes of disability and mortality in the twenty first century with future predictions painting an even graver story. Occupation, genome, and primarily smoking are the main causes of COPD. COPD is the third leading cause of death in America, claiming the lives of 134,676 Americans in 2010. Symptoms are typical of a constant smokers cough which progresses into the debilitating palliative stage of the disease; the development of co-morbidities exacerbates these symptoms. COPD has a complex pathophysiology involving hyperinflation, excessive mucus production and airway remodeling; diagnosis is through lung function tests. COPD is poorly managed with few effective treatments and a poor
COPD is almost always caused by smoking, or second hand smoke. The tobacco smoke irritates the airways and destroys the fibers in the lungs. Breathing in chemical fumes, dust, or air pollution over a long period of time may also cause it. It usually takes a long time for the lung damage to start causing symptoms, so COPD is most come in people who are older than 60.
Within the confines of this assignment, it is the hope of the author that the reader will obtain an understanding of Chronic Obstructive Pulmonary Disease (COPD). This will be achieved by bringing the reader through the patients’ illness journey. The assignment will begin by defining COPD and briefly going through the pathophysiology and incidents of the condition. From there the reader will embark on the journey, starting with diagnosis.
The cause of COPD is from long term smokers and also from people who smoke marijuana which increases a higher risk of COPD. Normally it begins with a cold or infection of the pharynx. Chest pain along with coughing having shortness of breath, and wheezing
Although the earliest references to COPD were recorded in the early 1600’s, it wasn’t until 1846 when John Hutchinson invented the diagnostic tool of the spirometer, that the disease was formally diagnosed. Then, in 1959 at the American Thoracic Society Committee on Diagnostic
The study included 100 patients with COPD. All patients fulfilled the inclusion and exclusion criteria. According to its demographic and clinical parameters and treatment groups differ among themselves. Completed the study, all patients included in the study. The therapy in all patients with a clinically meaningful improvement of symptoms was observed.
Chronic obstructive pulmonary disease (COPD) (http://www.thehealthsite.com/diseases-conditions/copd/001/) is considered one of the most common causes of death in the world today and, it appears that most of the patients are active smokers. However, according to researchers, the pulmonary disease can affect everybody, not only people who smoke.
Chronic bronchitis is a medical condition that enhances the swelling and mucus (phlegm or sputum) production in the breathing tubes (airways). Airway obstruction takes a place in chronic bronchitis, as the swelling and extra mucus cause the inside of the breathing tubes to be narrower than normal. This illness is the fourth leading cause of death and WHO predicted that COPD will be the third leading cause of death by 2030. Spirometry is the most recommended diagnostic test to assess as to whether a patient has a COPD or not by Glob initiative in Obstructive Lung disease (GOLD). This test is specifically designed to identify abnormalities in lung volumes and air flow. Spirometry is utilized along with physical assessment, medical history notes, x-rays and blood tests to confirm the type of lung disease that a patient is suffering from, which enables timely diagnosis and treatment. Spirometry can be defined as a mechanism that illustrate the degree of airflow obstruction with a forced expiratory volume per second (FEV1) of <0.7. This review will focus on the recent developments spirometry as a diagnostic tool for COPD .
There are many factors that contribute to the diagnosis of COPD. Smoking is the most common cause behind the disease. According to Healthline Networks,
There are no cure for this disease. However, there are different treatment to prevent further deterioration of the lungs function in order to improve the quality of life of the patient by increasing capacity of their physical activity. One of the main severe complication a patient with COPD can develop is exacerbation. Increased breathlessness, increased sputum volume and purulent sputum are the signs and symptoms of exacerbation. Early detection of the signs of exacerbation can help keep the condition of the patient from worsening. The treatments of COPD mainly aims at controlling the symptoms of exacerbation such as taking inhalers. Patients who are over the age of 35 and ex-smokers with chronic cough and bronchitis are recommended to have spirometer (NICE, 2004). This is because it is possible to delay or prevent patients from developing severe case of COPD is identified before they lose their lungs functions. Oxygen therapy is another treatment for COPD as the patients with this condition has high
I will analyse the prevalence of the condition and what the potential causes may be. My interests have been directed to pre hospital care and community lead treatment packages, which are potentially available to the patient, as this is the acute environment, which I will have contact with in my employment as a paramedic. The initial reading was to understand COPD as a chronic condition, what is COPD? and its prevalence in the population. The (World health organisation, 2000), states that one in four deaths in the world are caused by COPD. In 2010 (Vos T Flaxman etal, 2012), says globally there were approximately 329 million, which is 4.8% of the population who are affected by this chronic condition, In the UK (NICE, 2010), have estimated that 3 million people suffer from COPD, with more yet to be diagnosed. This information about the amount of people living with this condition was surprising, as I little knowledge of its existence. During the early 1960’s (Timothy Q. Howes, 2005), says the term COPD had been designated as a single term unifying all the chronic respiratory diseases. Since then the term COPD, has been sub divided in to three umbrella areas, Bronchitis, Emphysema and Chronic asthma, which are separate conditions, which I have been previously aware of as their individual conditions. The 58 year old patient who we visited,
All over the world, chronic obstructive pulmonary disease (COPD) is a very significant and prevalent cause of morbidity and mortality, and it is increasing with time (Hurd, 2000; Pauwels, 2000; Petty, 2000). Due to the factor of COPD being an underdiagnosed and undertreated disease, the epidemiology (Pauwels, Rabe, 2004) is about 60 to 85 % with mild or moderate COPD remaining undiagnosed (Miravitlles et al., 2009; Hvidsten et al., 2010).